1Abramson Family Cancer Research Institute; 2Howard Hughes Medical Institute; 3Department of Cell and Developmental Biology; 4Penn Molecular Profiling Facility, Bioinformatics Group; 5Department of Pathology and Laboratory Medicine; 6Department of Cancer Biology; 7Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; and 8INSERM U1037, Institut Claudius Regaud, Rue du Pont St Pierre, Toulouse, France.
Cancer Discov. 2014 Jan;4(1):53-60. doi: 10.1158/2159-8290.CD-13-0291. Epub 2013 Nov 4.
Inactivation of the von-Hippel Lindau (VHL) tumor suppressor gene occurs in 90% of human clear cell renal cell carcinomas (ccRCC) and leads to the stable expression of the hypoxia-inducible factors HIF1α and HIF2α. The constitutive expression of HIF1α in a majority of VHL-deficient tumors is counterintuitive, given that HIF1α functions as a tumor suppressor in ccRCC, whereas HIF2α clearly enhances tumor growth. We demonstrate here that miR-30c-2-3p and miR-30a-3p specifically bind and inhibit expression of HIF2A transcripts, and that the locus encoding miR-30c-2-3p and miR-30a-3p is selectively repressed in "H1H2" VHL-deficient tumors expressing both HIF1α and HIF2α proteins. Inhibiting miR-30a-3p expression increases HIF2α levels in H1H2 ccRCC cells and promotes cellular proliferation, angiogenesis, and xenograft tumor growth. Our results indicate that miR-30c-2-3p and miR-30a-3p repression enhances HIF2α expression and suggests a mechanism whereby the tumor-suppressive effects of constitutive HIF1α expression are attenuated in VHL-deficient H1H2 tumors.
von-Hippel Lindau(VHL)肿瘤抑制基因失活发生于 90%的人透明细胞肾细胞癌(ccRCC)中,并导致缺氧诱导因子 HIF1α和 HIF2α 的稳定表达。鉴于 HIF1α 在 ccRCC 中作为肿瘤抑制因子发挥作用,而 HIF2α 显然增强肿瘤生长,因此 VHL 缺陷肿瘤中 HIF1α 的组成型表达是违背直觉的。我们在此证明,miR-30c-2-3p 和 miR-30a-3p 特异性结合并抑制 HIF2A 转录物的表达,并且编码 miR-30c-2-3p 和 miR-30a-3p 的基因座在表达 HIF1α 和 HIF2α 蛋白的“H1H2”VHL 缺陷肿瘤中被选择性抑制。抑制 miR-30a-3p 的表达会增加 H1H2 ccRCC 细胞中的 HIF2α 水平,并促进细胞增殖、血管生成和异种移植肿瘤生长。我们的结果表明,miR-30c-2-3p 和 miR-30a-3p 的抑制增强了 HIF2α 的表达,并提示了一种机制,即 VHL 缺陷的 H1H2 肿瘤中组成型 HIF1α 表达的肿瘤抑制作用被减弱。